1d
ReShape Lifesciences Inc. RSLS gained 43.3% to $1.55 in pre-market trading. ReShape Lifesciences shares dipped around 54% on ...
The shares have sprung back to life thanks to China’s new stimulus programs—and Alibaba’s AI ventures. They stand to gain as much as 48%.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback